⚕ GalenOps CRO console
← 709 (USA)

709-1099

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 709 (USA) (Dr. Novak) · consented 2013-10-25
Adverse events
8
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild ACROCHORDON EXCISION — outcome: RECOVERED/RESOLVED; onset 2014-03-23 (study day 150.0); relationship: NONE

mild assessed 2026-08-18

Mild APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-12 (study day 19.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-12 (study day 19.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-12 (study day 19.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-12 (study day 19.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE VESICLES — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-12 (study day 19.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild NASOPHARYNGITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-06 (study day 13.0); relationship: NONE

mild assessed 2026-08-18

Mild NASOPHARYNGITIS — outcome: RECOVERED/RESOLVED; onset 2013-11-06 (study day 13.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.